Validation of a portable hand-held lactate analyzer for determination of blood lactate in patients on antiretroviral therapy in Uganda

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 5, 2008, Pages 564-566

  Kiragga, Agnes K ^a   Ocama, Ponsiano ^a   Reynolds, Steven J ^b   Kambugu, Andrew ^a   Ojiambo, Henry ^a   Castelnuovo, Barbara ^a  

^a Infectious Diseases Institute   (Uganda)

^b Rakai Health Services Program   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; STAVUDINE; ANTIRETROVIRUS AGENT; LACTIC ACID DERIVATIVE;

BLOOD SAMPLING; COST BENEFIT ANALYSIS; ENZYME ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LETTER; PATIENT REFERRAL; PHOTOMETRY; PORTABLE EQUIPMENT; PRIORITY JOURNAL; UGANDA; VALIDATION PROCESS; BLOOD; HOSPITAL INFORMATION SYSTEM; HUMAN; REPRODUCIBILITY; VALIDATION STUDY;

ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; LACTATES; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; UGANDA;

EID: 62749140146     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31817e6391     Document Type: Letter

References (11)

1. Moyle GJ, Datta D, Mandalia S, et al. Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS. 2002;16:1341-1349.
2. Mwebaze P, Castelnuovo B, Birabwa EM, et al. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda). Clin Infect Dis. 2007;45:514-517.
3. Bolhaar MG, Karstaedt AS. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis. 2007;45:514-517.
4. Coghlan M, Sommadossi JP, Jhala NC, et al. Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis. 2001;33:1914-1921.
5. Accutrend ® Lactate [package insert]. Product Information. Roche Diagnostics; 2003.
6. Lactate.com. Accusport/Accutrend pricing information. January 22, 2008. Available at: http://www.lactate.com/pricing.html. Accessed December 02, 2008.
7. Lactate test strips [package insert]. Product Information. Mannheim, Germany: Roche Diagnostics; 2007.
8. Bland JM, Altaian DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
9. Slomovitz BM, Lavery RF, Tortella BJ, et al. Validation of a hand-held lactate device in determination of blood lactate in critically injured patients. Crit Care Med. 1998;26: 1523-1528.
10. Bishop D. Evaluation of the Accusport® Lactate Analyzer, Mannheim, Germany. Int J Sports Med. 2001;22:525-530.
11. Boldt J, Kumle B, Suttaer S, et al. Pointof-care (POC) testing of lactate in the intensive care patient. Accuracy, reliability, and costs of different measurement systems. Acta Anaesthesiol Scand. 2001;45:194-199.